Vascular targeting in hepatocellular carcinoma with VEGFR-2 specific immunoliposomes containing doxorubicin

被引：0
|
作者：
Roth, P.
Hammer, C.
Piguet, A-C.
Dufour, J-F.
Waelti, E.
机构：
[1] Univ Bern, Div Immunopathol, Inst Pathol, CH-3012 Bern, Switzerland
[2] Univ Bern, Inst Clin Pharmacol, CH-3012 Bern, Switzerland
来源：
JOURNAL OF HEPATOLOGY | 2006年 / 44卷
关键词：
D O I：
10.1016/S0168-8278(06)80369-7
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
369
引用
收藏
页码：S141 / S141
页数：1
相关论文
共 50 条
  • [1] Effects on hepatocellular carcinoma of doxorubicin-loaded immunoliposomes designed to target the VEGFR-2
    Roth, Patrik
    Hammer, Caroline
    Piguet, Anne-Christine
    Ledermann, Monika
    Dufour, Jean-Francois
    Waelti, Ernst
    JOURNAL OF DRUG TARGETING, 2007, 15 (09) : 623 - 631
  • [2] SPECIFIC TARGETING OF HUMAN HEPATOCELLULAR-CARCINOMA CELLS BY IMMUNOLIPOSOMES IN-VITRO
    MORADPOUR, D
    COMPAGNON, B
    WILSON, BE
    NICOLAU, C
    WANDS, JR
    HEPATOLOGY, 1995, 22 (05) : 1527 - 1537
  • [3] SPECIFIC TARGETING OF HUMAN HEPATOCELLULAR-CARCINOMA CELLS BY IMMUNOLIPOSOMES IN-VITRO
    MORADPOUR, D
    COMPAGNON, B
    NICOLAU, C
    WANDS, JR
    HEPATOLOGY, 1994, 20 (04) : A277 - A277
  • [4] Targeting of tumor-associated angiogenic tip and stalk cells with immunoliposomes (ILs) directed against VEGFR-2 and VEGFR-3
    Wicki, A.
    Rochlitz, C.
    Orleth, A.
    Ritschard, R.
    Herrmann, R.
    Alitalo, K.
    Christofori, G.
    Mamot, C.
    ONKOLOGIE, 2011, 34 : 238 - 238
  • [5] Expression of pERK and VEGFR-2 in advanced hepatocellular carcinoma and resistance to sorafenib treatment
    Negri, Francesca V.
    Dal Bello, Barbara
    Porta, Camillo
    Campanini, Nicoletta
    Rossi, Sandro
    Tinelli, Carmine
    Poggi, Guido
    Missale, Gabriele
    Fanello, Silvia
    Salvagni, Stefania
    Ardizzoni, Andrea
    Maria, Silini Enrico
    LIVER INTERNATIONAL, 2015, 35 (08) : 2001 - 2008
  • [6] Lack of somatic mutations in VEGFR-2 tyrosine kinase domain in hepatocellular carcinoma
    Chuah, Benjamin Y. S.
    Yeo, Wee-Lee
    Guo, Jia Yi
    Lim, Seng-Gee
    Yap, Hui-Ling
    Goh, Boon-Cher
    Lee, Soo-Chin
    ACTA ONCOLOGICA, 2009, 48 (04) : 628 - 630
  • [7] Convenient preparation of tumor-specific immunoliposomes containing doxorubicin
    Nam, SM
    Cho, JE
    Son, BS
    Park, YS
    JOURNAL OF BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1998, 31 (01): : 95 - 100
  • [8] Selective targeting of tumor-associated angiogenic tip and stalk cells with immunoliposomes (ILs) directed against VEGFR-2 and VEGFR-3 expressing cells
    Wicki, Andreas
    Rochlitz, Christoph
    Orleth, Annette
    Ritschard, Reto
    Alitalo, Kari
    Herrmann, Richard
    Christofori, Gerhard
    Mamot, Christoph
    CANCER RESEARCH, 2011, 71
  • [9] Targeting Vascular Endothelial Growth Factor Receptor 2 (VEGFR-2): Latest Insights on Synthetic Strategies
    Marques, Carolina S.
    Brandao, Pedro
    Burke, Anthony J.
    MOLECULES, 2024, 29 (22):
  • [10] Indoline ureas as potential anti-hepatocellular carcinoma agents targeting VEGFR-2: Synthesis, in vitro biological evaluation and molecular docking
    Eldehna, Wagdy M.
    Fares, Mohamed
    Ibrahim, Hany S.
    Aly, Mohamed H.
    Zada, Suher
    Ali, Mamdouh M.
    Abou-Seri, Sahar M.
    Abdel-Aziz, Hatem A.
    El Ella, Dalai A. Abou
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2015, 100 : 89 - 97
12345